Spago Nanomedical AB (publ) (STO:SPAGO)

Spago Nanomedical AB Revenue

Spago Nanomedical AB had revenue of 1.07M SEK in the quarter ending March 31, 2026, a decrease of -29.05%. This brings the company's revenue in the last twelve months to 4.38M, down -37.31% year-over-year. In the year 2025, Spago Nanomedical AB had annual revenue of 4.82M, down -30.25%.

• Revenue (ttm): 4.38M
• Revenue Growth: -37.31%
• P/S Ratio: 17.35
• Revenue / Employee: 876.80K
• Employees: 5
• Market Cap: 76.08M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.82M	-2.09M	-30.25%
Dec 31, 2024	6.91M	982.00K	16.56%
Dec 31, 2023	5.93M	-529.00K	-8.19%
Dec 31, 2022	6.46M	-72.00K	-1.10%
Dec 31, 2021	6.53M	-714.00K	-9.85%
Dec 31, 2020	7.25M	-11.77M	-61.89%
Dec 31, 2019	19.02M	-10.71M	-36.03%
Dec 31, 2018	29.72M	11.43M	62.48%
Dec 31, 2017	18.29M	7.53M	69.89%
Dec 31, 2016	10.77M	2.86M	36.17%
Dec 31, 2015	7.91M	-25.00K	-0.32%
Dec 31, 2014	7.93M	-782.00K	-8.97%
Dec 31, 2013	8.72M	-1.40M	-13.83%
Dec 31, 2011	10.11M	4.17M	70.14%
Dec 31, 2010	5.94M	453.87K	8.27%
Dec 31, 2009	5.49M	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error